The Effect of Telemonitoring on Anxiety and Quality of Life in Patients in COVID 19 Quarantine
COVID-19 Pandemic
About this trial
This is an interventional supportive care trial for COVID-19 Pandemic focused on measuring telemedicine, anxiety, quarantine, Quality of Life
Eligibility Criteria
Inclusion Criteria:
- Volunteer patients who were diagnosed with COVID 19, over the age of 18, had no communication problems, were literate, had no diagnosed mental pathology, were able to use smartphones were included in the study
Exclusion Criteria:
- In the study, a patient whose general condition deteriorated during the COVID 19 quarantine and was hospitalized was excluded from the sample
Sites / Locations
- Arzu Bahar
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Tele-monitoring group
Plasebo group
The researchers called the patients in the experimental group on the first day of the quarantine and explained the topics covered in the COVID 19 patient education booklet to the patients. Patient education and follow-up in quarantine took approximately 25-30 minutes for each patient in the experimental group. The patients in quarantine were followed up by the researchers two more times, on the 5th and 9th days of the quarantine. On the 10th and last day of the quarantine, post-test online questionnaires were sent to the patients for the second time, and the data collection phase was ended.
The patients in the control group were called by the researchers on the first day of the quarantine and asked to fill in the online pre-test forms. On the 10th day, the last day of the quarantine, the patients were called and the online post-test forms were sent for the second time, and the data were collected. There was no telephone follow up in the control group and the patients received only routine care in the home